Airway Stent Lung Stent

Airway Stent Lung Stent Market Outlook

The global airway stent lung stent market is expected to reach approximately USD 1.5 billion by 2035, growing at a robust CAGR of around 6.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of respiratory diseases, particularly lung cancer and chronic obstructive pulmonary disease (COPD), which demand effective intervention strategies such as stenting. Additionally, advancements in stent technology, including the development of bioresorbable stents and the integration of imaging technologies to guide placement, are set to drive market growth. Increasing geriatric population, rising awareness regarding minimally invasive procedures, and favorable reimbursement policies further support the expansion of this market, fostering an environment conducive to innovation and product development.

Growth Factor of the Market

Several key factors are driving the growth of the airway stent lung stent market. Firstly, the rising incidence of respiratory disorders, including lung cancer and tracheal stenosis, is prompting a higher demand for airway stenting procedures. With an aging population and increasing smoking rates globally, the need for effective therapeutic solutions has never been higher. Secondly, advancements in medical technology contribute to the efficacy and safety of stenting procedures, making them more appealing for healthcare providers and patients alike. Thirdly, the development of innovative stent designs, such as biodegradable and hybrid stents, is enhancing treatment outcomes and patient satisfaction. Moreover, the expanding healthcare infrastructure, especially in emerging economies, is increasing access to high-quality medical services, which, in turn, is likely to boost market growth. Finally, rising healthcare expenditure and supportive government initiatives to improve healthcare access are also significant growth factors in this market.

Key Highlights of the Market

• The global airway stent lung stent market is projected to reach USD 1.5 billion by 2035.
• Significant CAGR of around 6.5% is anticipated during the forecast period.
• Increasing prevalence of lung cancer and COPD is driving market demand.
• Technological advancements in stent designs are improving patient outcomes.
• Rising healthcare expenditures and supportive policies are enhancing market accessibility.

By Product Type

Self-Expandable Stents:

Self-expandable stents are gaining popularity due to their ease of use and adaptability to various airway anatomies. These stents are designed to automatically expand when deployed, providing immediate relief from obstructions caused by tumors or other lesions. Ideal for long-term use, they are particularly beneficial in patients with conditions like tracheal stenosis. The self-expanding nature of these stents ensures that they conform to the airway's shape, reducing the likelihood of migration and improving overall stability. Consequently, the demand for self-expandable stents is surging, as healthcare providers recognize their advantages in enhancing patient comfort and treatment outcomes.

Balloon-Expandable Stents:

Balloon-expandable stents are characterized by their unique deployment mechanism, which involves the use of a balloon to expand the stent within the airway. This type of stent is particularly effective for conditions where precise expansion is necessary. The balloon is inflated to the desired diameter, allowing the stent to be positioned accurately before being deployed. Healthcare professionals often prefer balloon-expandable stents for their ability to create a stable and compliant airway, especially in patients with dynamic airway issues. The market for balloon-expandable stents is expected to grow as advancements in imaging technologies and minimally invasive techniques enhance their practical application in clinical settings.

Metallic Stents:

Metallic stents are a staple in airway management due to their strength and durability. Manufactured from materials such as stainless steel and nitinol, these stents provide significant structural support, making them suitable for various applications, including lung cancer and tracheobronchial fistulas. Their rigidity ensures that they maintain patency in obstructed airways over extended periods, thus preventing re-stenosis. The growing demand for metallic stents is driven by their proven efficacy, coupled with the continuous innovation in stent design that improves their flexibility and deployability. As a result, the metallic stent segment is anticipated to experience substantial growth in the coming years.

Silicone Stents:

Silicone stents are an alternative to metallic stents, favored for their biocompatibility and flexibility. These stents are often used in patients requiring temporary airway support due to conditions such as bronchomalacia or tracheobronchial fistula. Their soft structure minimizes irritation to the airway tissues, making them ideal for long-term use without significant adverse effects. Additionally, silicone stents can be easily removed or replaced, providing a versatile option for healthcare providers. As awareness of the benefits of silicone stents increases, this segment is expected to see growth, particularly among patients requiring extended airway management.

Hybrid Stents:

Hybrid stents, which combine features of both metallic and silicone stents, represent an innovative approach to airway management. These stents are designed to provide the structural integrity of metallic stents while incorporating the flexibility and comfort of silicone models. The versatility of hybrid stents allows them to be used effectively in various clinical scenarios, from treating lung cancer to providing support in patients with complex airway anatomies. The growing acceptance of hybrid stents among healthcare professionals, along with continued research and development, positions this segment for significant growth in the airway stent market.

By Application

Lung Cancer:

Lung cancer is one of the leading causes of morbidity and mortality worldwide, contributing significantly to the demand for airway stenting procedures. Airway stents are frequently utilized to relieve obstructions caused by tumors, facilitating easier breathing and improving quality of life for affected patients. Given the increasing prevalence of lung cancer, coupled with the aging population, the demand for innovative treatment options is expected to rise. As more healthcare providers adopt stenting as part of their treatment protocols, this application segment is poised for substantial growth over the forecast period.

Tracheal Stenosis:

Tracheal stenosis, a narrowing of the trachea that can lead to significant respiratory difficulties, is another major application driving the airway stent market. Stenting is often employed to maintain airway patency in patients with this condition, ensuring effective ventilation and preventing potential complications. The increasing incidence of tracheal stenosis, driven by factors such as chronic inflammation and trauma, underscores the need for effective airway management solutions. The consistent advancements in stent design and technology are making stenting procedures more effective and safer, thereby enhancing treatment options for patients suffering from tracheal stenosis.

Bronchomalacia:

Bronchomalacia, characterized by the weakening of bronchial walls, can lead to airway collapse and breathing difficulties, necessitating stenting for effective management. Stents are used to provide support to the bronchial passages, ensuring that air can flow freely and reducing the risk of airway obstruction. As the awareness of bronchomalacia increases among healthcare professionals, the application of airway stents in managing this condition is likely to grow. The development of stents specifically designed for bronchomalacia patients is also contributing to the segment's expansion, as these products offer tailored solutions for effectively addressing airway support needs.

Tracheobronchial Fistula:

Tracheobronchial fistulas are abnormal connections between the trachea and bronchi, often resulting from trauma or advanced disease states. Treatment of this condition frequently involves the use of stents to occlude the abnormal passage and restore normal airway function. The increasing incidence of tracheobronchial fistulas, particularly in patients with advanced malignancies or after surgical procedures, is driving the demand for effective stenting solutions. The growing understanding of this condition and advancements in stent technology are expected to propel growth in this application segment, providing critical support to patients in need of airway management.

Others:

In addition to the aforementioned applications, there are various other indications for airway stents, which contribute to the market's diversity. These may include conditions such as post-surgical airway complications, airway obstruction due to infections, or congenital anomalies. The use of stents in these scenarios is gaining traction as healthcare providers look for innovative ways to manage complex airway issues. The flexibility of airway stenting technology allows for customized solutions tailored to individual patient needs, thereby broadening the potential applications and driving growth in this segment.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for airway stents, with a significant volume of procedures being performed in these settings. The availability of specialized medical staff and advanced surgical facilities makes hospitals ideal environments for airway stenting interventions. Hospitals are increasingly adopting cutting-edge technologies and equipment that enhance patient outcomes, thereby contributing to the overall growth of the airway stent market. As hospitals continue to invest in advanced airway management solutions and expand their treatment capabilities, the demand for airway stents within this channel is expected to rise substantially.

Specialty Clinics:

Specialty clinics focused on respiratory disorders are emerging as vital distribution channels for airway stents. These clinics often provide targeted care for patients suffering from complex airway conditions, including lung cancer and tracheal stenosis. The concentrated expertise available in specialty clinics allows for personalized treatment plans and innovative stenting techniques, thereby enhancing patient outcomes. As the demand for specialized respiratory care increases, the role of specialty clinics in the airway stent market is likely to expand, providing a dedicated platform for the distribution of these critical medical devices.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) play a crucial role in the airway stent market by providing outpatient procedures that are cost-effective and convenient for patients. ASCs enable healthcare providers to perform stenting procedures with minimal disruption to patients’ daily lives, as these facilities often ensure faster recovery times and lower associated costs. The rising preference for outpatient procedures, driven by the increasing emphasis on patient convenience and satisfaction, is expected to bolster the demand for airway stents through ASCs. As healthcare systems continue to evolve, the importance of ASCs in providing accessible airway management solutions is set to grow significantly.

Online Sales:

The rise of e-commerce is transforming the distribution landscape for airway stents, allowing manufacturers to reach a broader audience through online sales channels. Although primarily utilized by healthcare providers and institutions, the availability of airway stents via online platforms is becoming increasingly popular. This trend is driven by the convenience of purchasing medical devices and the ability to compare products easily. As online sales platforms evolve, offering educational resources and detailed product information, the potential for increased market penetration through this channel is significant, thereby enhancing overall accessibility to airway stenting solutions.

By Material Type

Metallic Stents:

Metallic stents are widely recognized for their strength and durability, making them a popular choice in airway management. Constructed from robust materials such as stainless steel or nitinol, these stents provide the structural support necessary to maintain airway patency over extended periods. Their application is particularly prevalent in cases of malignant obstruction, such as lung cancer, where maintaining an open airway is crucial for patient survival. As advancements in metallic stent design continue to improve their flexibility and deployment ease, the segment is anticipated to witness considerable growth, supported by ongoing clinical evidence validating their effectiveness.

Silicone Stents:

Silicone stents offer significant advantages in airway management, particularly due to their biocompatibility and flexibility. These stents are used in various clinical situations, such as temporary airway support, where the primary goal is to minimize irritation to the airway tissues. Silicone stents can be easily inserted and removed, providing healthcare professionals with the ability to adapt treatment plans as needed. Their application in patients requiring long-term airway management is becoming increasingly recognized, making silicone stents a vital segment of the airway stent market as the demand for patient-centered care grows.

Nitinol Stents:

Nitinol stents, made from a nickel-titanium alloy, are gaining traction in the airway stent market due to their unique properties, including superelasticity and shape memory. These attributes allow nitinol stents to adapt to the airway's anatomical changes, ensuring optimal positioning and functionality. The ability to withstand bending and torsion without compromising structural integrity makes nitinol stents particularly suitable for complex airway anatomies. As research continues to validate the efficacy and safety of nitinol stents, the segment is expected to experience significant growth, driven by a growing recognition of their benefits in airway management.

Platinum Stents:

Platinum stents, characterized by their biocompatibility and inert nature, provide an alternative material option for airway stenting. These stents are particularly valuable in patients with metal allergies or sensitivities, offering a safe and effective solution for airway support. The use of platinum in stent design enhances the overall safety profile of the device, making it suitable for patients who may not tolerate traditional metallic stents. As awareness of platinum stents increases among healthcare providers, this segment is expected to grow as a niche but valuable option in airway management.

Stainless Steel Stents:

Stainless steel stents are a well-established choice in the airway stent market, known for their robustness and reliability. These stents are particularly effective in maintaining airway patency in patients with various obstructive conditions. The corrosion-resistant properties of stainless steel contribute to the stents' longevity and functionality, allowing for extended use without significant degradation. With ongoing advancements in stainless steel stent design and deployment techniques, this segment is likely to continue growing as healthcare professionals increasingly recognize the benefits of stainless steel in airway management.

By Region

The North American airway stent lung stent market is expected to dominate the global landscape, driven by a well-established healthcare infrastructure, high prevalence of chronic respiratory diseases, and significant investments in medical research and technology. The region is projected to achieve a CAGR of around 7% during the forecast period, supported by a growing emphasis on minimally invasive procedures and increasing awareness about treatment options among healthcare providers and patients. The U.S. stands out as the largest contributor to market growth, thanks to a robust healthcare system and advancements in stent technology. Additionally, favorable reimbursement policies and increasing collaboration between healthcare stakeholders are expected to play a pivotal role in driving the market in North America.

In Europe, the airway stent market is also on a growth trajectory, with increased focus on improving patient outcomes and expanding access to innovative medical devices. Countries such as Germany, the UK, and France are leading the charge, driven by the rising incidence of airway diseases and a growing demand for advanced therapeutic solutions. The European market is expected to grow at a CAGR of approximately 5.5%, supported by ongoing research initiatives and government funding aimed at enhancing respiratory healthcare. The increasing preference for outpatient procedures and specialty clinics for respiratory care further contributes to the expansion of the airway stent market in this region.

Opportunities

The airway stent lung stent market presents numerous opportunities for growth and expansion as advancements in technology continue to reshape the landscape of respiratory healthcare. One significant opportunity lies in the development of biodegradable airway stents, which are designed to dissolve naturally in the body after serving their purpose. This innovation addresses several critical challenges, including the risk of long-term complications associated with permanent stents and the need for subsequent procedures for removal. As healthcare providers and patients increasingly prioritize biocompatibility and reduced intervention risks, the demand for biodegradable stents is anticipated to surge, opening new avenues for market players to explore.

Moreover, the integration of digital health technologies, such as telemedicine and remote monitoring systems, into airway management can create additional opportunities for the market. By leveraging these technologies, healthcare providers can enhance patient care by incorporating regular monitoring and timely interventions, ultimately improving treatment outcomes. The growing trend of personalized medicine is also shaping the future of airway stenting, with tailored treatment plans designed to address individual patient needs more effectively. As these opportunities arise, market participants that invest in research, development, and partnerships with technology innovators are likely to gain a competitive edge in the evolving landscape of the airway stent lung stent market.

Threats

Despite the promising growth trajectory of the airway stent lung stent market, several threats could impede the overall progress of the industry. One significant concern is the increasing competition from alternative treatment modalities, such as laser therapy and bronchoscopic interventions, which may offer less invasive options for managing airway obstructions. As these alternative treatments gain traction due to their perceived advantages, the demand for traditional airway stenting may face challenges. Additionally, the ongoing pressures to reduce healthcare costs can lead to budget constraints for healthcare providers, which may limit the adoption of innovative stenting solutions in favor of more economical options. These factors may pose challenges for manufacturers and healthcare providers in maintaining market share and delivering high-quality airway management solutions.

Another potential threat to the airway stent market is the regulatory landscape, which continues to evolve and may impose stricter guidelines on the approval process for new devices. As regulatory agencies prioritize patient safety, companies must navigate an increasingly complex approval process that may delay the introduction of innovative products to the market. Moreover, any adverse events associated with airway stenting procedures could lead to heightened scrutiny and increased regulation, further complicating the landscape for market participants. In this dynamic environment, companies must remain vigilant and adaptable to successfully mitigate these threats while continuing to deliver safe and effective airway management solutions.

Competitor Outlook

• Boston Scientific Corporation
• Medtronic plc
• Cook Medical
• Terumo Corporation
• Smiths Medical
• Conmed Corporation
• Becton, Dickinson and Company
• Olympus Corporation
• Halyard Health, Inc.
• Stentys S.A.
• Pentax Medical
• Alvimedica
• Micro-Tech (Nanjing) Co., Ltd.
• AngioDynamics, Inc.
• W. L. Gore & Associates, Inc.

The competitive landscape of the airway stent lung stent market is characterized by the presence of several key players that are actively engaged in product development, innovation, and strategic partnerships to enhance their market positions. Major companies such as Boston Scientific Corporation and Medtronic plc dominate the market, leveraging their extensive research and development capabilities to introduce advanced stenting solutions. These organizations have established strong distribution networks and collaborations with healthcare providers, enabling them to reach a wider audience with their products. Additionally, they are continuously investing in clinical trials and studies to validate the effectiveness and safety of their airway stents, which is critical for gaining the confidence of healthcare professionals and patients alike.

Another notable player in the airway stent market is Cook Medical, which has been at the forefront of developing innovative airway management solutions. The company's commitment to research-driven advancements has resulted in the launch of new stent designs and materials that improve patient outcomes. Their focus on personalized medicine also positions them well to address the diverse needs of patients requiring airway interventions. Furthermore, collaborations with academic institutions and healthcare organizations enhance their ability to stay ahead of industry trends and develop cutting-edge products that meet evolving market demands.

Companies such as Terumo Corporation and Olympus Corporation are also making significant strides in the airway stent market. Terumo, known for its expertise in vascular intervention devices, is expanding its product portfolio to include advanced airway stenting solutions. Olympus, with its strong emphasis on endoscopic technologies, is well-positioned to innovate in airway stenting, providing healthcare professionals with effective tools for airway management. As these companies strive to enhance their product offerings and explore new market opportunities, the competitive landscape will continue to evolve, providing patients with access to a broader range of high-quality airway management solutions.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Alvimedica
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Cook Medical
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Stentys S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Pentax Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smiths Medical
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Conmed Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Terumo Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 AngioDynamics, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Olympus Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Halyard Health, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Becton, Dickinson and Company
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 W. L. Gore & Associates, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Micro-Tech (Nanjing) Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Airway Stent Lung Stent Market, By Application
    • 6.1.1 Lung Cancer
    • 6.1.2 Tracheal Stenosis
    • 6.1.3 Bronchomalacia
    • 6.1.4 Tracheobronchial Fistula
    • 6.1.5 Others
  • 6.2 Airway Stent Lung Stent Market, By Product Type
    • 6.2.1 Self-Expandable Stents
    • 6.2.2 Balloon-Expandable Stents
    • 6.2.3 Metallic Stents
    • 6.2.4 Silicone Stents
    • 6.2.5 Hybrid Stents
  • 6.3 Airway Stent Lung Stent Market, By Material Type
    • 6.3.1 Metallic Stents
    • 6.3.2 Silicone Stents
    • 6.3.3 Nitinol Stents
    • 6.3.4 Platinum Stents
    • 6.3.5 Stainless Steel Stents
  • 6.4 Airway Stent Lung Stent Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Airway Stent Lung Stent Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Airway Stent Lung Stent market is categorized based on

By Product Type

• Self-Expandable Stents
• Balloon-Expandable Stents
• Metallic Stents
• Silicone Stents
• Hybrid Stents

By Application

• Lung Cancer
• Tracheal Stenosis
• Bronchomalacia
• Tracheobronchial Fistula
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Sales

By Material Type

• Metallic Stents
• Silicone Stents
• Nitinol Stents
• Platinum Stents
• Stainless Steel Stents

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Medtronic plc
• Cook Medical
• Terumo Corporation
• Smiths Medical
• Conmed Corporation
• Becton, Dickinson and Company
• Olympus Corporation
• Halyard Health, Inc.
• Stentys S.A.
• Pentax Medical
• Alvimedica
• Micro-Tech (Nanjing) Co., Ltd.
• AngioDynamics, Inc.
• W. L. Gore & Associates, Inc.